The Chairman, President, CEO of Abiomed (ABMD) is Buying Shares


Today, the Chairman, President, CEO of Abiomed (NASDAQ: ABMD), Michael Minogue, bought shares of ABMD for $1.05M.

Following Michael Minogue’s last ABMD Buy transaction on August 20, 2015, the stock climbed by 325.1%. This recent transaction increases Michael Minogue’s holding in the company by 19.27% to a total of $233 million.

See today’s analyst top recommended stocks >>

Based on Abiomed’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $174 million and quarterly net profit of $36.85 million. In comparison, last year the company earned revenue of $125 million and had a net profit of $14.9 million. ABMD’s market cap is $18.96B and the company has a P/E ratio of 174.40. The Company has a Price to Book ratio of 27.4989.

13 different firms, including BTIG and Goldman Sachs, currently also have a Buy rating on the stock. Based on 6 analyst ratings, the analyst consensus is Strong Buy with an average price target of $409.40, reflecting a 1.7% upside.

The insider sentiment on Abiomed has been positive according to 85 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.

Michael Minogue’s trades have generated a 19.1% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded in 1981 and is headquartered in Danvers, MA.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts